Rohitashva Agrawal
Rohitashva Agrawal
Contributor, The Yuan

Rohitashva Agrawal is a physician who holds a Fellowship in Digital Health Innovations from Harvard Medical School. He is passionate about access to quality healthcare and expressing opinions on impactful technologies. Besides clinical medicine, he has worked in consulting, non-profit, academia and government across the US, India and Africa at different levels.

GenAI offers a peek into the future of empathetic care in neuropsychiatry
Brain science
Neuropsychiatric disorders are often difficult to treat because each patient’s case is unique and there are few, if any, other comparable cases to use as references. Fortunately, GenAI, a new tech, is now changing this outlook, argues Harvard Med Fellow Rohitashva Agrawal, MD,MPH.
Rohitashva Agrawal  |  Apr 17, 2024
Can AI deliver long-awaited breakthroughs in assessing stroke risk?
Domain knowledge
Medical professionals toil hard to gauge stroke risk among aging populations earlier and more accurately. Incremental improvements have come, but big breakthroughs remain elusive as lack of access to care and AI jitters thwart efforts, as Harvard Med Fellow Rohit Agrawal, MD, MPH explains.
Rohitashva Agrawal  |  Mar 28, 2024
AI activates neuroscience to map the brain’s terra incognita
Brain science
One of the most consequential developments taking place today is the AI-driven transformation of neuroscience, which is helping medical professionals uncover new insights and discover more about neural structures and the brain, as Harvard Med Fellow Rohit Agrawal, MD, elaborates.
Rohitashva Agrawal  |  Jan 25, 2024
AI governance in the Global South might require additional guardrails
AI regulation is harder in emerging markets like India, Brazil etc. whose unique local conditions and cultural requirements mean that - unlike wealthier counterparts - a locally acceptable regulatory edifice must be built from the ground up to shield the vulnerable, states Harvard Med Fellow Rohit Agrawal, MD, MPH.
Rohitashva Agrawal  |  Jan 03, 2024
AI can unleash nuclear medicine’s potential, boost it to new heights
Nuclear medicine uses radioactive material to diagnose and treat disease more precisely than traditional methods. Coupled with advancements in AI, it has a chance to make even more progress in the coming years, above all in India, states Harvard Med-trained Dr Rohitashva Agrawal.
Rohitashva Agrawal  |  Aug 29, 2023
Proliferation of smartphones, GAI trigger a sea change in healthcare
The ongoing digital revolution - and especially the advent of the smartphone - has transformed many industries, yet healthcare still lags, but accessible, affordable, convenient, personalized healthcare is now starting to become available to more than ever before.
Rohitashva Agrawal  |  Jul 24, 2023
Open Medical Data - Digitization, AI Integration, and Ethical Considerations
There is great potential for integrating AI and digitization in healthcare, as well as ethical issues. In the second part of our converstation, Rohitashva Agrawal discusses the hurdles of adopting new technology, "boring" advancements, lifelong learning, the value of teamwork, and emerging trends.
Delta Dialog  |  Jul 14, 2023
Open Medical Data - Transforming Healthcare: AI, ChatGPT, Blockchain, and the Metaverse
Blockchain, the metaverse, chatGPT, AI, and other technologies could revolutionize healthcare. Discover the difficulties and possibilities raised by Rohitashva Agrawal as we examine how to combine innovation and regulation, make use of medical data, and ensure data security in the age of health applications.
Delta Dialog  |  Jul 07, 2023
India’s AI governance trajectory to influence the whole world
India’s AI governance is ever more influential worldwide in step with its status as the fastest-growing major economy. The most populous nation must now decide how much regulation is too much, or it risks stifling innovation, explains ex-Harvard Medical fellow Dr Rohitashva Agrawal.
Rohitashva Agrawal  |  May 29, 2023
Potential applications of ChatGPT in healthcare in India
New era
ChatGPT is revolutionary and, despite its flaws, may still be the next big thing in healthcare, above all in India where the existing health system is deficient, but many elements of ChatGPT still need more rigorous vetting before it deploys in a regulated healthcare environment.
Rohitashva Agrawal  |  Mar 01, 2023
The Yuan AI 2023: A year when health innovation is set to mature and consolidate
The Yuan AI 2023
As 2023 gets underway, AI-related innovation in health tech companies is likely to be as affected by war, inflation, energy shortages, and available funding as by tech advances. Consolidation is likely, which may reduce competition, though even if trendy startups and eye-catching but risky ventures struggle, ‘boring’ innovation that often flies under the radar will continue to rack up successes. Harvard fellow Dr Rohitashva Agrawal explains.
Rohitashva Agrawal  |  Jan 03, 2023
Medical blockchain dovetails with other tech
Now synonymous with cryptocurrency, blockchain also has key applications in healthcare, from securing data, to tailoring treatments to individual patients. Dr Rohitashva Agrawal foresees vast changes on the horizon from the tech’s growing deployment in medicine.
Rohitashva Agrawal  |  Dec 16, 2022
Metaverse in medicine: hope or dope?
Much has been made of the Metaverse and its potential for change, and this is certainly so in healthcare. Amid all the hype, it is important to take a look at what the Metaverse actually is and what is now possible as this gives insights into which aspects have the most success, which have not, and what the future of the Metaverse in medicine and other fields is.
Rohitashva Agrawal  |  Nov 02, 2022
AI reimbursement to turbocharge medtech revolution
Applications for reimbursement of AI-related healthcare costs are arduous and time-consuming, a huge burden that disproportionately affects startups and other small firms. Accelerated adoption of new technology spurred by the COVID-19 pandemic may at last be about to change this situation.
Rohitashva Agrawal  |  Sep 14, 2022
Barriers to adopting digital pathology in developing economies and mitigation strategy
Hurdles to digitalizing pathology are falling, even in developing nations. Competition and innovation keep cutting the costs of digitalization, which the pandemic has hastened, and its benefits outweigh brief hiccups from one-off shifts to the new technology, as Dr Rohitashva Agrawal explains.
Rohitashva Agrawal  |  Aug 04, 2022
Open health data will help fix India's healthcare
Open Data 2022
Drawbacks aside, India will benefit from the vast potential of its medical data. The data of the country home to one-sixth of humanity form a force that must be harnessed for the betterment of its healthcare, urges Dr Rohitashva Agrawal in his contribution to The Yuan’s Open Data 2022 series that commemorates the 110th anniversary of Alan Turing’s birth.
Rohitashva Agrawal  |  Jul 06, 2022
Expected Changes in the Regulation of Health Apps
Health apps have proliferated of late, partly due to the COVID-19 pandemic, but their quality and reliability is often uneven. Data security and user privacy laws have also lagged. Regulation must keep pace as health-tracking and other emerging technologies continue developing. Dr Rohitashva Agrawal wonders whether the world is up to the challenge.
Rohitashva Agrawal  |  Jun 03, 2022
Digital Pathology Presents a Great Opportunity for India
Recent advances in digital pathology are an opportunity for India to become a world leader. Digitization and automation are critical in helping India overcome its shortage of specialized medical professionals, especially in rural areas, and make more efficient use of the ones it has. Can India use the advantages of a huge population, growing middle class, and vast pools of data to leapfrog other countries?
Rohitashva Agrawal  |  Apr 14, 2022